Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05609942
Title	Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies (AZURE)
Acronym	AZURE
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Blueprint Medicines Corporation
Indications	systemic mastocytosis hematologic cancer mast-cell leukemia
Therapies	Elenestinib Azacitidine + Elenestinib
Age Groups:	senior \| adult
Covered Countries	USA \| NOR \| NLD \| FRA \| ESP \| DEU \| BEL